FDA launches safety review of two RSV drugs for infants as RFK Jr. scrutinizes immunizations
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr. No safety issues have been reported with either of the respiratory syncytial virus drugs: Beyfortus, from Sanof…